Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

September 15, 2024

Study Completion Date

September 15, 2025

Conditions
Colorectal CancerEsophageal CancerStomach CancerPancreatic CancerMetastatic TumorRecurrent Cancer
Interventions
BIOLOGICAL

CEA CAR-T cells

Administration method: intravenous infusion or intraperitoneal injection; Subjects will be treated with Fludarabine and Cyclophosphamide before cell infusion.

Trial Locations (1)

250000

RECRUITING

Shandong Second Provincial General Hospital, Jinan

All Listed Sponsors
lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY